Wall Street Zen

Company

Last mentioned: Mar 18, 2026

Timeline

  1. Insider Selling

    President and another insider report share sales in regulatory filings.

  2. Analyst Downgrade

    Wall Street Zen cuts ALHC rating to Hold.

  3. Offering Priced

    Secondary offering is priced at $19.46 per share.

  4. Secondary Offering Announced

    Company announces intent to sell 13.2 million shares to raise capital.

  5. Q4 Earnings Report

    Alignment Healthcare reports a declining net loss for the fourth quarter of 2025.

Stories mentioning Wall Street Zen 2

About Wall Street Zen coverage

This page surfaces every story mentioning Wall Street Zen across our healthcare coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.

Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running healthcare beat. Cross-entity comparisons live on our compare view.

What you seeWhat it tells you
Story countNumber of distinct stories where Wall Street Zen was a primary or referenced actor.
Recency clusteringWhether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc).
Sentiment distributionAggregate sentiment of the stories mentioning this entity, weighted by impact score.
Cross-niche linksWhen the same entity surfaces in our sibling networks, we link to those views to enrich context.